Detalles de la búsqueda
1.
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Br J Haematol
; 194(3): 496-507, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33724461
2.
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol
; 178(1): 61-71, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28382618
3.
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Haematologica
; 101(11): 1398-1406, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662018
4.
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Biol Blood Marrow Transplant
; 21(12): 2039-2051, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26428082
5.
European Myeloma Network guidelines for the management of multiple myeloma-related complications.
Haematologica
; 100(10): 1254-66, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26432383
6.
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
Lancet Oncol
; 15(12): e538-48, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25439696
7.
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.
Haematologica
; 99(6): 984-96, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24658815
8.
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
Blood
; 117(18): 4691-5, 2011 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-21292775
9.
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.
Blood
; 117(18): 4696-700, 2011 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-21292777
10.
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy.
Blood
; 117(7): 2121-8, 2011 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21163927
11.
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).
Blood
; 118(17): 4519-29, 2011 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21841166
12.
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
Blood
; 117(23): 6063-73, 2011 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21447828
13.
The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling.
Eur J Haematol
; 90(4): 263-72, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23311753
14.
Cross-cultural differences in information disclosure evaluated through the EORTC questionnaires.
Psychooncology
; 22(2): 268-75, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22052786
15.
The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases.
Eur J Haematol
; 88(5): 406-15, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22309072
16.
Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.
Clin Dev Immunol
; 2012: 134081, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22481961
17.
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom).
Blood
; 113(18): 4137-43, 2009 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19182205
18.
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.
Blood
; 114(9): 1729-35, 2009 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-19561323
19.
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation.
Clin Dev Immunol
; 2011: 302145, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22190969
20.
Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma.
Eur J Haematol
; 84(4): 337-44, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20028416